Top searches

PL

Resources

B2RLaw advises biotech company Ambulero on fundraising

27/01/2021

B2RLaw has advised Ambulero, Inc., a biotechnology company developing cell and gene therapy treatments for patients suffering from vascular disease on funding of up to USD 5.5 million received from from Orphinic Scientific.

As part of the investment, and with the help of B2RLaw, Ambulero and Orphinic formed a Polish subsidiary (Ambulero Sp. z o.o.) that will lead clinical testing of a novel gene therapy for a serious vascular disease in Europe. The disease is rare in the US but more common in certain parts of Central and Eastern Europe.

Ambulero is a biotechnology company dedicated to advancing a platform of cell and gene therapies to treat serious vascular diseases. The company is a 2019 spin-out of the University of Miami co-founded by Robert L. Buchanan, Randy Berholtz, Omaida C. Velazquez and Jun Zhao-Liu. It holds an exclusive license from the University of Miami to develop and commercialize research from the laboratories of Drs. Omaida C. Velazquez and Jun Zhao-Liu.

With offices in Palo Alto, California and Warsaw, Poland, Orphinic Scientific is an innovative drug development and investment company focused on mid-market opportunities and orphan drugs in late preclinical research and Phase 1 or 2.

B2RLaw’s team was led by Partner Szymon Syp and included Senior Associate Iga Wojtczak – Opala and Junior Associate Jakub Niemiec.

Szymon Syp advises, “We congratulate Ambulero and Orphinic Scientific on this transaction. Ambulero’s important work means that people that suffer from serious vascular disease (which at best, causes severe discomfort and at worst, can result in death) can live in comfort with the knowledge that innovative treatment is on the horizon. We wish Ambulero the best of luck on its future clinical testing”.

View more resources

Catch up on the very latest B2RLAW
announcements and news here.

16/05/2023

Andrzej Zając appointed as a Head of the Energy & Real Estate Practice in B2RLaw

Andrzej is an attorney-at-law with almost 20 years of professional experience. Andrzej is a lawyer focusing his practice on complex […]

MORE
17/04/2023

B2RLaw announces lawyer promotions

We are very pleased to announce five lawyer promotions in B2RLaw in its 2022/2023 promotion round. The lawyers that have […]

MORE
28/04/2023

B2RLaw at the IFG Asset Recovery Conference: 27-28 April in Toronto

Meet our B2RLaw team: Edyta Zalewska (Advocate, Partner) and Roman Iwański (Advocate, Partner) at the Annual Spring Members’ Meeting! We are […]

MORE
13/04/2023

B2RLaw recommended in the Legal 500 EMEA ranking 2023

We are proud to announce that in this year’s edition of The Legal 500 we have been recommended in 6 […]

MORE
04/04/2023

B2RLaw one of only 6 law firms in Poland recognized by Legal 500 in its Green Guide EMEA 2023

We are pleased to announce that B2RLaw has been inducted into the 2023 second edition of Legal 500’s Europe, Middle […]

MORE
28/03/2023

B2RLaw advises Bentley Systems’ Cohesive Group on its acquisition of Vetasi

B2RLaw has advised Bentley Systems, Incorporated, the infrastructure engineering software company, and its Cohesive Group digital integrator business, on the […]

MORE

Get in touch

Not sure who to contact? Let us help you find the right lawyer.

This site uses cookies to improve your experience More information.

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close